Manher Joshi

Insider Reports History

Identity
Location
Thousand Oaks, CA
SEC record
Reporting signature
/s/ Anish Bhatnagar, Attorney-in-Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Manher Joshi:

Form 4 holding EVP, Chief Medical Officer

Atara Biotherapeutics, Inc.

Security class
Common Stock
Shares / value
171,284
Estimated value
$66,629
Report date
16 Nov 2023
Price
$0.3890
Ownership
Direct
Form 4 holding Chief Development Officer

SOLENO THERAPEUTICS INC

Security class
Employee stock option (right to buy)
Shares / value
4,700
Estimated value
Report date
21 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Development Officer

SOLENO THERAPEUTICS INC

Security class
Stock Option (Right to buy)
Shares / value
0
Estimated value
Report date
18 May 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Manher Joshi

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .